Skip to content
healthcare.dev
Get a free key

Bortezomib

NDC 68083-651, Bortezomib, injection, powder, lyophilized, for solution, from Gland Pharma Limited.

Product NDC
68083-651
Status
Listed
Labeler
Gland Pharma Limited
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219167
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68083-651 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BORTEZOMIB2.5 mg/1

Pharmacologic classes

Proteasome Inhibitor [EPC]; Proteasome Inhibitors [MoA]

Package NDCNDC-11Package
68083-651-01680830651011 VIAL, SINGLE-DOSE in 1 CARTON (68083-651-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 68083-651 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68083-651 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68083-651. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.